Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,082Revenue (TTM) $M32,574Net Margin (%)0.3Altman Z-Score3.0
Enterprise Value $M16,137EPS (TTM) $0.1Operating Margin %1.7Piotroski F-Score5
P/E(ttm)108Beneish M-Score-2.5Pre-tax Margin (%)0.4Higher ROA y-yN
Price/Book14.110-y EBITDA Growth Rate %--Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.35-y EBITDA Growth Rate %17.2Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-11.2ROA % (ttm)0.8Higher Current Ratio y-yY
Dividend Yield %--PEG6.6ROE % (ttm)15.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M1,052ROIC % (ttm)6.6Gross Margin Increase y-yN

Gurus Latest Trades with RAD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RADDavid Einhorn 2016-09-30 Add0.46%$6.82 - $8.21
($7.46)
$ 8.6716%Add 30.14%13,443,035
RADLeucadia National 2016-09-30 Add0.22%$6.82 - $8.21
($7.46)
$ 8.6716%Add 40.83%1,208,291
RADJohn Paulson 2016-09-30 Sold Out -0.05%$6.82 - $8.21
($7.46)
$ 8.6716%Sold Out0
RADMario Gabelli 2016-09-30 Reduce$6.82 - $8.21
($7.46)
$ 8.6716%Reduce -1.15%1,369,975
RADDavid Einhorn 2016-06-30 Buy 1.42%$7.49 - $8.19
($7.89)
$ 8.6710%New holding10,330,000
RADLeucadia National 2016-06-30 Buy 0.74%$7.49 - $8.19
($7.89)
$ 8.6710%New holding857,991
RADGeorge Soros 2016-06-30 Sold Out -0.11%$7.49 - $8.19
($7.89)
$ 8.6710%Sold Out0
RADJohn Paulson 2016-06-30 Add0.03%$7.49 - $8.19
($7.89)
$ 8.6710%Add 120.46%580,900
RADMario Gabelli 2016-06-30 Add0.02%$7.49 - $8.19
($7.89)
$ 8.6710%Add 29.85%1,385,875
RADJoel Greenblatt 2016-06-30 Sold Out -0.01%$7.49 - $8.19
($7.89)
$ 8.6710%Sold Out0
RADFirst Eagle Investment 2016-03-31 Sold Out -0.11%$7.58 - $8.15
($7.88)
$ 8.6710%Sold Out0
RADGeorge Soros 2016-03-31 Reduce-0.05%$7.58 - $8.15
($7.88)
$ 8.6710%Reduce -38.17%500,000
RADJohn Paulson 2016-03-31 Buy 0.02%$7.58 - $8.15
($7.88)
$ 8.6710%New holding263,500
RADMario Gabelli 2016-03-31 Add0.02%$7.58 - $8.15
($7.88)
$ 8.6710%Add 48.77%1,067,250
RADJoel Greenblatt 2016-03-31 Reduce-0.01%$7.58 - $8.15
($7.88)
$ 8.6710%Reduce -57.17%71,752
RADKen Fisher 2016-03-31 Sold Out $7.58 - $8.15
($7.88)
$ 8.6710%Sold Out0
RADJoel Greenblatt 2015-12-31 Reduce-0.14%$6.05 - $8.67
($7.43)
$ 8.6717%Reduce -93.28%167,539
RADGeorge Soros 2015-12-31 Buy 0.12%$6.05 - $8.67
($7.43)
$ 8.6717%New holding808,700
RADMario Gabelli 2015-12-31 Buy 0.04%$6.05 - $8.67
($7.43)
$ 8.6717%New holding717,400
RADFirst Eagle Investment 2015-12-31 Add0.01%$6.05 - $8.67
($7.43)
$ 8.6717%Add 12.02%5,627,170
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RAD is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RAD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Donley Douglas ESVP 2016-06-15Sell34,106$7.7711.58view
Montini TonyEVP 2015-07-09Sell353,194$8.383.46view
ANDERSON JOSEPH B JRDirector 2015-04-15Sell150,000$8.255.09view
Thompson Robert KEVP 2015-04-13Sell95,850$8.334.08view
SYMS MARCYDirector 2015-04-10Sell150,000$8.264.96view
Donley Douglas ESVP & CAO 2015-04-10Sell59,404$8.215.6view
Montini TonyEVP 2014-12-29Sell49,525$7.4716.06view
Montini TonyEVP 2014-12-23Sell259,750$6.9225.29view
STANDLEY JOHN TChairmain/CEO 2014-12-22Sell1,700,000$6.8227.13view
STRASSLER MARC AEVP 2014-12-22Sell575,975$6.7927.69view

Quarterly/Annual Reports about RAD:

News about RAD:

Articles On GuruFocus.com
Dividend Aristocrats in Focus Part 38: Walgreens Boots Alliance Nov 10 2016 
Why I Am Now Interested in CVS Health Corporation Oct 13 2016 
Rite Aid Is a Solid Risk Arbitrage Trade Sep 27 2016 
Why Walgreens Is a Long-Term Buy Now Sep 09 2016 
David Einhorn Adds Calpine, Rite Aid, Amaya to Portfolio Aug 16 2016 
CVS and Walgreens: A Duopoly That's Hard to Ignore Jul 08 2016 
In Spite of Less Revenue Rite Aid Still Has Growth Potential Jun 21 2016 
Walgreens Boots Alliance: 40 Consecutive Years of Dividend Growth and Counting Jun 17 2016 
Undervalued Stocks With Low PE Mar 24 2016 
Is CVS Pharmacy Undervalued? Feb 22 2016 

More From Other Websites
Week In Review: Trump Murders Drug Stocks; Apple Breaks Out; GM Bullish Jan 13 2017
Rite Aid Foundation Welcomes New Year with New Class of KidCents Charities Jan 12 2017
After Walgreens’s 1Q17 Results, Wall Street Remains Positive Jan 12 2017
Walgreens-Rite Aid Merger OK Seen Before Trump Takes Office Jan 11 2017
RITE AID CORP Financials Jan 11 2017
Walgreens Expects a Stronger 2017, Thanks to New Deals Jan 11 2017
[$$] The Grinch Stole Christmas Jan 09 2017
[$$] CVS Has an Edge on Walgreens Jan 06 2017
Walgreens Raises Low End Of Outlook But Q1 Revenue Falls Short Jan 05 2017
RITE AID CORP Files SEC form 10-Q, Quarterly Report Jan 05 2017
Walgreens Boots (WBA) Beats Q1 Earnings, Trims EPS View Jan 05 2017
Walgreens Expects 2017 Rebound As New PBM Deals Take From CVS Jan 05 2017
Walgreens Misses Revenue but Beats Earnings Target -- Slightly Jan 05 2017
Post Earnings Coverage as Rite Aid Top- and Bottom-line Below Market Expectations Jan 05 2017
[$$] Comings & Goings Jan 03 2017
Rite Aid (RAD): Where Does the Stock Stand Post Earnings? Jan 03 2017
[$$] Getting Rite Aid to Fit Dec 31 2016
Best performing retailers Dec 30 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)